(Q37813524)

English

Considerations when submitting nanotherapeutics to FDA/CDER for regulatory review

scientific article published on January 2011

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit